NLS Pharmaceutics AG (NLSP)
BIOTECHNOLOGY
Last updated: Nov 16, 2026 at 4:00 PM ET
NLS Pharmaceutics AG (NLSP) Stock Chart
NLS Pharmaceutics AG (NLSP) closed at $2.75 on Nov 16, 2026. Its price fell 19.8% over the past 12 months. The month-end price fell 99.7% over the 5 years through Oct 2026, a compound annual decline of 68.8%.
Price Chart
From Jan 2021 to Oct 2026, its highest month-end close was $1,616.00 in Mar 2021 and its lowest $1.90 in Dec 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NLSP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NLSP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 18.9%, and over 6 months it fell 11.6%. The month-end price fell 99.0% over the 3 years through Oct 2026, a compound annual decline of 78.7%.
| Period | Change |
|---|---|
| 1 month | +10.0% |
| 3 months | -18.9% |
| 6 months | -11.6% |
| 12 months | -19.8% |
| 12 months, with dividends | -19.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.0% | -78.7% |
| 5 years | -99.7% | -68.8% |
Price by Year
Its best calendar year was 2022, when the price rose 16.2%, and its weakest was 2024, when it fell 91.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.55 | +34.2% |
| 2025 | $1.90 | -91.0% |
| 2024 | $21.10 | -91.1% |
| 2023 | $235.96 | -54.3% |
| 2022 | $516.00 | +16.2% |
Trading Range
The price is 4.7% below its 50-day average of $2.89 and 11.6% below its 200-day average of $3.11.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $2.75 | |
| 50-day average | $2.89 | -4.7% |
| 200-day average | $3.11 | -11.6% |
Price Risk
Over 3 years, its largest fall from a peak was 99.2%.
| Measure | Value |
|---|---|
| 1-year beta | 0.87 |
| Largest fall, 1 year | -58.7% |
| Largest fall, 3 years | -99.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NLSP
What is NLSP's 1-year price change?
NLS Pharmaceutics AG's price fell 19.8% over the past 12 months. With dividends included, the 12-month total return was -19.8%.
What is NLSP's 5-year price change?
NLS Pharmaceutics AG's month-end price fell 99.7% over the 5 years through Oct 2026, a compound annual decline of 68.8%. These figures leave out dividends.
What is NLSP's beta?
NLS Pharmaceutics AG's 1-year beta against the S&P 500 is 0.87, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 58.7%.
Is the NLSP chart free?
Yes. Advanced Charting for NLSP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.